We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCO icon
3151
Arcos Dorados Holdings
ARCO
$1.7B
$224K ﹤0.01%
31,617
-2,569
-8% -$16.9K
SAFE
3152
Safehold
SAFE
$1.13B
$224K ﹤0.01%
+3,710
New +$178K
ASXC
3153
DELISTED
Asensus Surgical, Inc.
ASXC
$224K ﹤0.01%
12,663
-102
-0.8% -$2.23K
CSII
3154
DELISTED
Cardiovascular Systems, Inc.
CSII
$224K ﹤0.01%
+5,211
New +$202K
ABR icon
3155
Arbor Realty Trust
ABR
$978M
$223K ﹤0.01%
18,400
+4,518
+33% +$58.7K
KFY icon
3156
Korn Ferry
KFY
$4.28B
$223K ﹤0.01%
5,562
-2,527
-31% -$115K
PEJ icon
3157
Invesco Leisure and Entertainment ETF
PEJ
$306M
$223K ﹤0.01%
5,154
+1
+0% +$43
PRLB icon
3158
Protolabs
PRLB
$2.13B
$223K ﹤0.01%
1,919
-248
-11% -$26.7K
RWW
3159
DELISTED
Invesco S&P Financials Revenue ETF
RWW
$223K ﹤0.01%
3,285
-400
-11% -$26.5K
ALEX
3160
DELISTED
Alexander & Baldwin
ALEX
$222K ﹤0.01%
9,627
-346
-3% -$8.21K
MVV icon
3161
ProShares Ultra MidCap400
MVV
$162M
$222K ﹤0.01%
5,445
NXP icon
3162
Nuveen Select Tax-Free Income Portfolio
NXP
$900M
$222K ﹤0.01%
14,517
+1,752
+14% +$26.3K
FNSR
3163
DELISTED
Finisar Corp
FNSR
$222K ﹤0.01%
9,728
-1,500
-13% -$34.4K
CWEN icon
3164
Clearway Energy Class C
CWEN
$6.64B
$221K ﹤0.01%
13,112
-3,661
-22% -$57.8K
GNT
3165
GAMCO Natural Resources, Gold & Income Trust
GNT
$146M
$221K ﹤0.01%
37,944
-11,537
-23% -$63.8K
LOB icon
3166
Live Oak Bancshares
LOB
$1.97B
$221K ﹤0.01%
12,909
-2,630
-17% -$43.2K
IHG icon
3167
InterContinental Hotels
IHG
$23.2B
$220K ﹤0.01%
+3,289
New +$215K
JPM icon
3168
CALL
JPMorgan Chase
JPM
$953B
$220K ﹤0.01%
208,700
+32,600
+19% +$3.59M
WBT
3169
DELISTED
Welbilt, Inc.
WBT
$220K ﹤0.01%
13,154
+343
+3% +$5.61K
SAFE
3170
DELISTED
Safehold Inc.
SAFE
$220K ﹤0.01%
+7,284
New +$194K
FCF icon
3171
First Commonwealth Financial
FCF
$2.19B
$218K ﹤0.01%
16,215
-1,000
-6% -$13.2K
VVV icon
3172
Valvoline
VVV
$4.41B
$218K ﹤0.01%
11,173
+1,059
+10% +$19.6K
ASG
3173
Liberty All-Star Growth Fund
ASG
$342M
$217K ﹤0.01%
37,209
+8,652
+30% +$49K
IVH
3174
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
$217K ﹤0.01%
16,012
+4,301
+37% +$58.6K
SEMG
3175
DELISTED
SEMGROUP CORPORATION
SEMG
$217K ﹤0.01%
+18,093
New +$240K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.